Covid-19 Vaccine Could Extend Survival of Brain Cancer Patients

A recent study has found that patients diagnosed with glioblastoma, a deadly brain cancer, can have extended survival durations if they receive an mRNA Covid-19 shot not more than 100 days before they undergo surgery to remove the tumor.

For now, the scientific community is desperate for any intervention that can benefit glioblastoma patients since the disease has defied all existing treatments, and they welcome the findings of this study. Hopefully, the R&D efforts of entities like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) could yield a breakthrough that transforms glioblastoma treatment in the&

Read More>>

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

You May Also Be Interested In

• Tampa General Hospital Secures Funding to Establish Center for Lymphatic Education and Research
• LithiumBank Announces Non-Brokered Private Placement
• Polkadot Price Prediction Turns Heads After a Breakout While Pepeto Gives Early Wallets the Bigger Shot